Gene editing is a group of technologies that enable scientists to precisely alter an organism's DNA. These technologies allow for the addition, removal, or alteration of genetic material at specific ...

Research shows IDT's UNCOVERseq™ achieved the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods.

Genome editing is a powerful biotechnology tool that allows scientists to make precise changes to an organism's DNA. It involves the use of specialized enzymes, known as engineered nucleases or ...

Scientists have made many advances using traditional CRISPR technology, especially in medicine, but they are now seeking ways ...

Within bacterial cells, specialized immune systems known as retrons fend off viral attacks. But that's not all they can do. Scientists, including Seth Shipman, Ph.D., at Gladstone Institutes, have ...

Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed a revolutionary new method to improve compact gene-editing tools known as base ...

Gene editing has the potential to become another life-changing breakthrough, but only if it is guided by ethics instead of ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...

On Tuesday, the team behind the plan to bring mammoth-like animals back to the tundra announced the creation of what it is calling wooly mice, which have long fur reminiscent of the woolly mammoth.

RNA could be considered DNA’s younger sibling. From the very beginning, RNA’s milestones came later and attracted less attention than DNA’s milestones. For example, the discovery of DNA’s structure ...

Discover the top gene editing stocks to watch. Learn about this groundbreaking field and the companies leading advancements ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular ...